Jonah Murdock, MD
Urology · Greenbelt, MDNPI 1689840928
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $870 of the $1,412 with a category attached, or 61.6%. Procept Biorobotics Corporation accounts for 68.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $1,171 and has fallen 89.7% since, to $121 in 2024. That places this record below the midpoint for urology clinicians in MD, where the typical reported total is $4,190.
Across 22 payments — averaging $64.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$960
- AbbVie$131
- Dornier Medtech America, Inc$71
- Boston Scientific$62
- Olympus America Inc.$55
- Philips North America LLC$35
- plus $98 from 4 others
Across 2 payments — averaging $10,800 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$22K
What the payments were for
- Travel & lodging$87062%
- Food & beverage$54238%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 5 | $960 |
| AbbVie | 5 | $131 |
| Dornier Medtech America, Inc | 1 | $71 |
| Boston Scientific | 3 | $62 |
| Olympus America Inc. | 3 | $55 |
| Philips North America LLC | 1 | $35 |
| Blue Earth Diagnostics | 1 | $29 |
| Laborie Medical Technologies Corp. | 1 | $25 |
| Merck | 1 | $24 |
| Dentsply IH Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,412 in reported general payments places this provider in the 35th percentile of 274 urology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Citrate ErPotassium Citrate | 12 | $2,274 |
| Tamsulosin Hcl | 21 | $258 |
Paid to pharmacies, not to this prescriber.
Other urology in Greenbelt
- Matthew AllawayCumberland$20.6M
- Benjamin LowentrittBaltimore$549K
- Julio DavalosGlen Burnie$490K
- Sankar KausikBel Air$375K
- Laura GiustoOwings Mills$367K
- Amin HeratiBaltimore$160K
- Rian DicksteinHanover$144K
- Max KatesBaltimore$139K
- Arthur BurnettBaltimore$132K
- Aaron WeinbergBaltimore$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.